J Sany
About
In The Last Decade
J Sany
208 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Rheumatology 4.8k
- Hematology 2.9k
- Genetics 2.2k
- Immunology 1.8k
- Oncology 1.6k
Countries citing papers authored by J Sany
This map shows the geographic impact of J Sany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Sany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Sany more than expected).
Fields of papers citing papers by J Sany
This network shows the impact of papers produced by J Sany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Sany. The network helps show where J Sany may publish in the future.
Co-authorship network of co-authors of J Sany
This figure shows the co-authorship network connecting the top 25 collaborators of J Sany. A scholar is included among the top collaborators of J Sany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Sany. J Sany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 167 | |
| 2 | Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed breakdown → | 512 |
| 3 | 1 | |
| 4 | 25 | |
| 5 | Traitement de la polyarthrite rhumatoïde par des anticorps monoclonaux | 1 |
| 6 | 12 | |
| 7 | 102 | |
| 8 | Human mucosyl lymphocyte marker expression in synovial fluid lymphocytes of patient with rheumatoid arthritis. | 7 |
| 9 | Efficacy and tolerance of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone | 2 |
| 10 | Taux de maintenance thérapeutique du méthotrexate au cours de la polyarthrite rhumatoïde. Etude prospective de 191 cas. | 1 |
| 11 | 6 | |
| 12 | Valeur pronostique des récepteurs solubles de l'interleukine 2 présents dans le liquide synovial au cours de la polyarthrite rhumatoïde. | 2 |
| 13 | 29 | |
| 14 | Mises Au PointLes gonococcies articulairesGonococcal arthritis | 1 |
| 15 | [IgM kappa Waldenström's disease with cryoglobulinemia disclosed by visceral leishmaniasis]. | 1 |
| 16 | [Anemia in rheumatoid polyarthritis. Value of serum ferritin for the estimation of iron stores]. | 1 |
| 17 | Signification clinique des anticorps spécifiques d'antigènes nucléaires solubles. | 3 |
| 18 | 24 | |
| 19 | [Arthropathy of the shoulder caused by bismuth poisoning]. | 3 |
| 20 | Stimulation of lymphocytes from rheumatoid arthritis patients by mitogens and IgG. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.